IMS MAXIMS to Showcase Proven Dementia Software at Major Clinical Conference

IMS MAXIMSIMS MAXIMS will be demonstrating the benefits of their portfolio of user-focused solutions, including innovative dementia software, to a major clinical audience at the Acute and General Medicine conference in London, 27 - 28th November.

Delegates to the conference, which is expected to attract thousands of senior consultants over the two days, will have the opportunity to speak to representatives of IMS MAXIMS about how they create products and services that are easily adapted to suit each customer.

Furthermore, IMS MAXIMS representatives will be on stand F24 to talk about the organisation's strong track record of involving healthcare professionals at every stage of the development process, ensuring their needs and those of patients are given the highest priority.

This approach was clearly evident, as IMS MAXIMS customer Royal Cornwall Hospitals NHS Trust became one of the first in the country to exceed all its Commissioning Quality for Innovation (CQUIN) targets for dementia care. Using IMS MAXIMS' dementia software, developed based on The Department of Health's CQUIN requirements, the trust is now able to more effectively identify patients with dementia and other causes of cognitive impairment to enable a better referral process, reduced length of stays in hospital and effective follow-up care.

Frazer Underwood, associate director of nursing, Royal Cornwall Hospitals NHS Trust said: "The high profile of our dementia work in Cornwall means that the ability of IMS MAXIMS to contribute meaningfully to improving services is invaluable. We felt really engaged with IMS MAXIMS throughout the development process; they were driven by patient needs, delivering a system which put clinical requirements first."

In addition, IMS MAXIMS will also demonstrate its Patient Administration System (PAS), Electronic Patient Record (EPR) and Integrated Care Pathway solutions.

The MAXIMS PAS currently supports more than 11 million patient records in England and a further two million records in Ireland. The system allows healthcare professionals to replace paper-based systems with electronic records that are fast, efficient and accurate, helping both clinical and admin staff work more efficiently while improving patient safety.

The EPR enables a single, complete electronic patient record to be created that contains all relevant information about every aspect of the patient's care - historic notes, all correspondence, past and future appointments and care detail. Whilst the IMS MAXIMS Integrated Care Pathways allows clinicians to easily co-ordinate multiple care actions in a patient-centered approach, allowing care to be delivered efficiently and as quickly as possible.

Shane Tickell, CEO, IMS MAXIMS added: "The Acute and General Medicine conference provides us with an excellent platform to highlight our dementia module and other software solutions. We are committed to developing systems that support healthcare professionals to safely deliver the right care to patients at the right time. In this way, not only do we contribute to improving outcomes for patients but we also help healthcare organisations as they strive to address the multiple challenges that the NHS faces."

IMS MAXIMS will be exhibiting on stand F24; delegates are invited to come along to find out more about the company's current range of clinical healthcare information solutions.

About the Acute and General Medicine conference
Now in its second year the Acute and General Medicine conference (AGM) is expected to be attended by over 4,000 hospital doctors and NHS managers. The AGM programme allows doctors to follow their learning needs across the medical specialties with pacey, interactive seminars, uniquely offering knowledge and skills training in acute and general medicine.

About IMS MAXIMS
IMS MAXIMS is an electronic patient record provider working towards better, safer patient care. Specialists in developing clinical and administrative software solutions for healthcare providers, IMS MAXIMS currently supports more than 150 organisations, 11 million patient records in the UK, and 1.9 million patient records in Ireland, approx 50% of the population, as well as 20,000 users of IMS MAXIMS products.

IMS MAXIMS is at the heart of the clinical and administrative life of everything from large UK and Irish hospitals, to small specialist independent clinics. It gives patient data to clinicians in exactly the format they need, and allows it to be shared with colleagues and updated in real-time. MAXIMS suits any clinical specialism and is excellent for order communications and reporting. Medical and administrative records can be kept fully up to date, with minimum effort. MAXIMS is web-based so there is no need to install software on computers or invest in expensive extra hardware.

Most Popular Now

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...

Bayer Acquires HiDoc Technologies and Ca…

Bayer is today announcing that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to start commercialization of the digital health application, Cara Care®. Cara...

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...